Health
First Ever Drug For Early Breast Cancer Treatment Receives Approval In India
AstraZeneca India has received approval from the Drugs Controller General of India (DGCI) to market its drug for breast cancer treatment. Lynparza is the first and only approved medication in the market that targets breast cancer gene mutations in early-stage. As per data published in the World...
Trending
Covishield Jab Protection Against COVID-19 Wanes Just After 3 Months: Lancet Study
The Logical Indian Crew
Health
Study Proves Robust Immune Response After Mixing Vaccines With AstraZeneca, Pfizer
The Logical Indian Crew
Trending
Didn't Back Doubling Of Covishield Gap, Say Scientists; Government Denies
The Logical Indian Crew
Trending
Adar Poonawalla To Invest Over USD 300 Million In UK, May Manufacture Inoculations
The Logical Indian Crew